(18)F-DOPA PET/CT in the diagnosis and localization of persistent medullary thyroid carcinoma.

Date publication

juin 2016

Journal

European journal of nuclear medicine and molecular imaging

Auteurs

Membres identifiés du Cancéropôle Est :
Pr IMPERIALE Alessio

Tous les auteurs :
Archier A, Heimburger C, Guerin C, Morange I, Palazzo FF, Henry JF, Schneegans O, Mundler O, Abdullah AE, Sebag F, Imperiale A, Taïeb D

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/26497699

Résumé

To evaluate the performance of (18)F-L-dihydroxyphenylalanine ((18)F-DOPA) PET/CT in the detection of locoregional and distant medullary thyroid carcinoma (MTC) metastases and to compare imaging findings with histological data.

Mots clés

Adult, Aged, Aged, 80 and over, Calcitonin, metabolism, Carcinoma, Neuroendocrine, diagnostic imaging, Dihydroxyphenylalanine, analogs & derivatives, Female, Humans, Middle Aged, Positron Emission Tomography Computed Tomography, Prognosis, Retrospective Studies, Thyroid Neoplasms, diagnostic imaging, Young Adult

Référence

Eur. J. Nucl. Med. Mol. Imaging. 2016 Jun;43(6):1027-33